• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国银屑病的临床特征:一项针对12000多名患者的全国性调查。

Clinic characteristics of psoriasis in China: a nationwide survey in over 12000 patients.

作者信息

Chen Kun, Wang Gang, Jin Hongzhong, Xu Jinhua, Zhu Xuejun, Zheng Min, Gu Heng

机构信息

Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College,Nanjing, Jiangsu, China.

Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China.

出版信息

Oncotarget. 2017 Jul 11;8(28):46381-46389. doi: 10.18632/oncotarget.18453.

DOI:10.18632/oncotarget.18453
PMID:28637026
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5542274/
Abstract

Psoriasis is a worldwide chronic inflammatory disease, involving both skin and joints. In order to characterize psoriasis in Han Chinese population, we conducted this nationwide prospective and hospital based survey, in which 56 hospitals with departments of dermatology participated, located in 33 cities across China. A total of 12,031 outpatients with psoriasis were registered during 2009 to 2010, which the data was collected by standard questionnaires. The main data acquisition included demographics, family history, disease status and other comorbidities. Physical and dermatological examination, including body surface area (BSA) and psoriasis area severity index (PASI) were applied to evaluate the disease severity. Descriptive statistics, 2 tailed t-test and chi-square test were used appropriately for the statistical analysis. From the study, we found that the male and female ratio of the patients was 1.49:1. Mean age of onset was 30.2 ± 14.5 years for males and 27.1 ± 15.6 years for females (P < 0.05). Scalp was the most common onset site (52.8%), The mean PASI was 18.70 ± 10.01, indicating that most patients presenting at the hospitals had moderate-to-severe psoriasis and the majority was psoriasis vulgaris (96.5%). Among 12,031 patients, 23.1% had a family history of psoriasis,16.1% had comorbidities, and 29.9% had nail changes. The most important aggravation factor was season change (60.2%), followed by psychological stress (34.5%), and there significant differences between genders on trigger factors. In conclusion, this study characterizing psoriasis in Han Chinese population, could be used as basic data for future study.

摘要

银屑病是一种全球性的慢性炎症性疾病,累及皮肤和关节。为了对中国汉族人群中的银屑病进行特征描述,我们开展了这项全国性的前瞻性医院调研,来自中国33个城市的56家设有皮肤科的医院参与其中。2009年至2010年期间,共登记了12031例银屑病门诊患者,数据通过标准问卷收集。主要的数据采集包括人口统计学信息、家族史、疾病状况和其他合并症。采用体格检查和皮肤科检查,包括体表面积(BSA)和银屑病面积和严重程度指数(PASI)来评估疾病严重程度。描述性统计、双侧t检验和卡方检验被适当地用于统计分析。从研究中我们发现,患者的男女比例为1.49:1。男性的平均发病年龄为30.2±14.5岁,女性为27.1±15.6岁(P<0.05)。头皮是最常见的发病部位(52.8%),平均PASI为18.70±10.01,表明大多数到医院就诊的患者患有中度至重度银屑病,且大多数为寻常型银屑病(96.5%)。在12031例患者中,23.1%有银屑病家族史,16.1%有合并症,29.9%有指甲改变。最重要的加重因素是季节变化(60.2%),其次是心理压力(34.5%),触发因素在性别之间存在显著差异。总之,这项对中国汉族人群银屑病特征的研究,可作为未来研究的基础数据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97c2/5542274/b909e195a5cd/oncotarget-08-46381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97c2/5542274/b909e195a5cd/oncotarget-08-46381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/97c2/5542274/b909e195a5cd/oncotarget-08-46381-g001.jpg

相似文献

1
Clinic characteristics of psoriasis in China: a nationwide survey in over 12000 patients.中国银屑病的临床特征:一项针对12000多名患者的全国性调查。
Oncotarget. 2017 Jul 11;8(28):46381-46389. doi: 10.18632/oncotarget.18453.
2
Analysis for 208 children with psoriasis vulgaris.对208例寻常型银屑病患儿的分析。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 Jul 28;45(7):804-811. doi: 10.11817/j.issn.1672-7347.2020.190129.
3
Nail dystrophies, scalp and intergluteal/perianal psoriatic lesions: risk factors for psoriatic arthritis in mild skin psoriasis?甲营养不良、头皮和臀部/肛周银屑病皮损:轻度皮肤银屑病患者发生银屑病关节炎的危险因素?
G Ital Dermatol Venereol. 2014 Apr;149(2):177-84.
4
Severity of Psoriasis Differs Between Men and Women: A Study of the Clinical Outcome Measure Psoriasis Area and Severity Index (PASI) in 5438 Swedish Register Patients.银屑病的严重程度在男性和女性之间存在差异:一项对5438名瑞典登记患者的临床结局指标银屑病面积和严重程度指数(PASI)的研究。
Am J Clin Dermatol. 2017 Aug;18(4):583-590. doi: 10.1007/s40257-017-0274-0.
5
Oral PSORI-CM01, a Chinese herbal formula, plus topical sequential therapy for moderate-to-severe psoriasis vulgaris: pilot study for a double-blind, randomized, placebo-controlled trial.口服中药复方PSORI-CM01联合外用序贯疗法治疗中重度寻常型银屑病:一项双盲、随机、安慰剂对照试验的初步研究
Trials. 2016 Mar 16;17(1):140. doi: 10.1186/s13063-016-1272-x.
6
Concept of Remission in Chronic Plaque Psoriasis.慢性斑块状银屑病的缓解概念。
J Rheumatol Suppl. 2015 Nov;93:57-60. doi: 10.3899/jrheum.150638.
7
Childhood psoriasis: a study of 137 cases from central China.儿童银屑病:来自中国中部的 137 例研究。
World J Pediatr. 2010 Aug;6(3):260-4. doi: 10.1007/s12519-010-0213-0. Epub 2010 Jun 12.
8
The evaluation of the sociodemographic and clinical features of Turkish psoriasis patients.土耳其银屑病患者的社会人口统计学和临床特征评估。
Int J Dermatol. 2002 Apr;41(4):220-4. doi: 10.1046/j.1365-4362.2002.01462.x.
9
The skin in psoriasis: assessment and challenges.银屑病中的皮肤:评估与挑战。
Clin Exp Rheumatol. 2015 Sep-Oct;33(5 Suppl 93):S14-9. Epub 2015 Oct 15.
10
General psychiatric symptoms, quality of sleep, and coping strategies in patients with psoriasis vulgaris.寻常型银屑病患者的一般精神症状、睡眠质量及应对策略
Int J Dermatol. 2016 Jan;55(1):60-4. doi: 10.1111/ijd.12649. Epub 2015 May 6.

引用本文的文献

1
Development and Validation of an Artificial Intelligence-Driven Model for Accurate Classification of Erythrodermic Psoriasis Severity: Erythrodermic Psoriasis Integrated Classification System (EPICS).人工智能驱动的红皮病型银屑病严重程度准确分类模型的开发与验证:红皮病型银屑病综合分类系统(EPICS)
Am J Clin Dermatol. 2025 Aug 26. doi: 10.1007/s40257-025-00980-6.
2
Investigation of the Efficacy and Safety of Xeligekimab (GR1501) in Patients with Moderate-to-Severe Plaque Psoriasis: A Multicenter, Randomized, Double-Blind Phase II Clinical.Xeligekimab(GR1501)治疗中重度斑块状银屑病患者的疗效和安全性研究:一项多中心、随机、双盲II期临床试验。
Dermatol Ther (Heidelb). 2025 Jun 15. doi: 10.1007/s13555-025-01450-x.
3

本文引用的文献

1
Metabolic comorbidities and hypertension in psoriasis patients in France. Comparisons with French national databases.法国银屑病患者的代谢合并症和高血压。与法国国家数据库的比较。
Ann Dermatol Venereol. 2016 Apr;143(4):264-74. doi: 10.1016/j.annder.2015.06.024. Epub 2016 Mar 8.
2
Prevalence of psoriasis phenotypes among men and women in the USA.美国男性和女性中银屑病表型的患病率。
Clin Exp Dermatol. 2016 Jul;41(5):486-9. doi: 10.1111/ced.12805. Epub 2016 Feb 18.
3
Psoriasis and the Risk of Depression in the US Population: National Health and Nutrition Examination Survey 2009-2012.
Efficacy of Ixekizumab in Chinese Patients with Moderate-to-Severe Psoriasis and Special Body Area Involvement: Sub-analysis of a Randomized, Double-Blind, Multicenter Phase 3 Study.
司库奇尤单抗治疗中国中重度银屑病及特殊身体部位受累患者的疗效:一项随机、双盲、多中心3期研究的亚组分析
Adv Ther. 2025 Jan;42(1):146-163. doi: 10.1007/s12325-024-02976-w. Epub 2024 Sep 30.
4
The Safety of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: Analyses from a Prospective, Single-Arm, Multicenter, 12-Week Observational Study.依奇珠单抗在中国中重度斑块状银屑病成人患者中的安全性:一项前瞻性、单臂、多中心、12 周观察研究的分析。
Drug Saf. 2024 Jul;47(7):711-719. doi: 10.1007/s40264-024-01427-3. Epub 2024 Apr 30.
5
Effectiveness of Ixekizumab in Chinese Patients with Moderate-Severe Plaque Psoriasis with Special Area Involvement: Subanalysis of a Prospective, Multicenter, Observational Real-World Study.司库奇尤单抗治疗累及特殊部位的中国中重度斑块状银屑病患者的有效性:一项前瞻性、多中心、观察性真实世界研究的亚组分析
Dermatol Ther (Heidelb). 2024 Apr;14(4):907-918. doi: 10.1007/s13555-024-01134-y. Epub 2024 Mar 27.
6
Use of biologics in patients with psoriasis - A retrospective analysis based on real-world data.生物制剂在银屑病患者中的应用——基于真实世界数据的回顾性分析。
Skin Res Technol. 2024 Jan;30(1):e13550. doi: 10.1111/srt.13550.
7
Comorbidity Burden and Treatment Patterns of Psoriasis in Vietnam: Real-World Data from the EXPAND Study.越南银屑病的合并症负担及治疗模式:来自EXPAND研究的真实世界数据
Dermatol Ther (Heidelb). 2023 Dec;13(12):3193-3208. doi: 10.1007/s13555-023-01062-3. Epub 2023 Nov 17.
8
Safety and Efficacy of Ixekizumab in Chinese Adults with Moderate-to-Severe Plaque Psoriasis: A Prospective, Multicenter, Observational Study.Ixekizumab 在中国中重度斑块型银屑病成人患者中的安全性和疗效:一项前瞻性、多中心、观察性研究。
Adv Ther. 2023 Dec;40(12):5464-5474. doi: 10.1007/s12325-023-02672-1. Epub 2023 Oct 12.
9
Cost-Effectiveness of Secukinumab Versus Other Biologics in the Treatment of Moderate-to-Severe Plaque Psoriasis: The Chinese Healthcare System Perspective.司库奇尤单抗与其他生物制剂治疗中重度斑块状银屑病的成本效益:中国医疗保健系统视角
Dermatol Ther (Heidelb). 2023 Nov;13(11):2681-2696. doi: 10.1007/s13555-023-01041-8. Epub 2023 Sep 23.
10
Treatment outcomes of secukinumab in adult patients with moderate-to-severe plaque psoriasis in China: A real-world multicenter retrospective study.中国中重度斑块型银屑病成年患者司库奇尤单抗治疗结局:一项真实世界、多中心回顾性研究。
Clin Transl Sci. 2023 Oct;16(10):1803-1814. doi: 10.1111/cts.13583. Epub 2023 Aug 29.
银屑病与美国人群抑郁风险的关系:2009-2012 年全国健康和营养调查。
JAMA Dermatol. 2016 Jan;152(1):73-9. doi: 10.1001/jamadermatol.2015.3605.
4
Clinical features of psoriatic arthritis in Korean patients with psoriasis: a cross-sectional observational study of 196 patients with psoriasis using psoriatic arthritis screening questionnaires.韩国银屑病患者银屑病关节炎的临床特征:一项使用银屑病关节炎筛查问卷对196例银屑病患者进行的横断面观察研究。
Rheumatol Int. 2016 Feb;36(2):207-12. doi: 10.1007/s00296-015-3365-3. Epub 2015 Sep 22.
5
Prevalence and Clinical Characteristics of Psoriatic Arthritis in Japan.日本银屑病关节炎的患病率及临床特征
J Rheumatol. 2015 Aug;42(8):1439-42. doi: 10.3899/jrheum.141598. Epub 2015 Jun 15.
6
Genetic Factors Explain Variation in the Age at Onset of Psoriasis: A Population-based Twin Study.遗传因素解释银屑病发病年龄的差异:一项基于人群的双胞胎研究。
Acta Derm Venereol. 2016 Jan;96(1):35-8. doi: 10.2340/00015555-2171.
7
Genetic Epidemiology of Psoriasis.银屑病的遗传流行病学
Curr Dermatol Rep. 2014 Mar;3(1):61-78. doi: 10.1007/s13671-013-0066-6.
8
Psoriasis and metabolic syndrome: a systematic review and meta-analysis of observational studies.银屑病与代谢综合征:观察性研究的系统评价和荟萃分析。
J Am Acad Dermatol. 2013 Apr;68(4):654-662. doi: 10.1016/j.jaad.2012.08.015. Epub 2013 Jan 27.
9
Global epidemiology of psoriasis: a systematic review of incidence and prevalence.全球银屑病流行病学:发病率和患病率的系统评价。
J Invest Dermatol. 2013 Feb;133(2):377-85. doi: 10.1038/jid.2012.339. Epub 2012 Sep 27.
10
Prevalence of psoriasis in China: a population-based study in six cities.中国银屑病患病率的一项基于人群的六城市研究。
Eur J Dermatol. 2012 Sep-Oct;22(5):663-7. doi: 10.1684/ejd.2012.1802.